HomeInsights52 Week High Stocks

Parmax Pharma Ltd 52 Week High

Parmax Pharma Ltd 52 Week High

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

1.8 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

YEARHIGH

₹ 54

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week HIGH of Parmax Pharma Ltd is ₹ 54 as of 20 Dec 24 .

Company Fundamentals for Parmax Pharma Ltd

No data available

Market Price of Parmax Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 202443.7
19 Dec 202446
18 Dec 202443.84
17 Dec 202446.08
16 Dec 202448.5
13 Dec 202447
12 Dec 202445
11 Dec 202445.28
10 Dec 202444.75
09 Dec 202447.1

Asset Value vs Market Value of Parmax Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Parmax Pharma Ltd

No data available

* All values are in crore

Parmax Pharma Ltd News Hub

News

Parmax Pharma to discuss results

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November ...

Read more

07 Nov 2024 11:45

News

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Sep 2024 16:46

News

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 20...

Read more

09 Aug 2024 14:53

News

Parmax Pharma revises board meeting date

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be ...

Read more

29 May 2024 12:10

News

Parmax Pharma schedules board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 28 May 2024 ...

Read more

24 May 2024 12:53

News

Parmax Pharma to hold board meeting

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 February ...

Read more

09 Feb 2024 16:10

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Parmax Pharma Ltd

What is the significance of Parmax Pharma Ltd reaching its 52-week high?

Parmax Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Parmax Pharma Ltd 52-week high?

Investors monitor Parmax Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Parmax Pharma Ltd a good buy when it hits its 52-week high?

Whether Parmax Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Parmax Pharma Ltd fundamentals.

What should I consider before investing in Parmax Pharma Ltd at its 52-week high?

Before investing in Parmax Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Parmax Pharma Ltd stock price continue to rise after reaching its 52-week high?

Parmax Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions